<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35600979</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-199X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>19</Volume>
            <PubDate>
              <Year>2023</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Bioactive materials</Title>
          <ISOAbbreviation>Bioact Mater</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation.</ArticleTitle>
        <Pagination>
          <StartPage>666</StartPage>
          <EndPage>677</EndPage>
          <MedlinePgn>666-677</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bioactmat.2022.04.033</ELocationID>
        <Abstract>
          <AbstractText>An increased level of reactive oxygen species (ROS) plays a major role in endothelial dysfunction and vascular smooth muscle cell (VSMC) proliferation during in-stent thrombosis and restenosis after coronary artery stenting. Herein, we report an electrospun core-shell nanofiber coloaded with 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPOL) and rapamycin (RAPA) that correspondingly serves as an ROS scavenger and VSMC inhibitor. This system has the potential to improve the biocompatibility of current drug-eluting stent (DES) coatings with the long-term and continuous release of TEMPOL and rapamycin. Moreover, the RAPA/TEMPOL-loaded membrane selectively inhibited the proliferation of VSMCs while sparing endothelial cells (ECs). This membrane demonstrated superior ROS-scavenging, anti-inflammatory and antithrombogenic effects in ECs. In addition, the membrane could maintain the contractile phenotype and mitigate platelet-derived growth factor BB (PDGF-BB)-induced proliferation of VSMCs. <i>In vivo</i> results further revealed that the RAPA/TEMPOL-loaded covered stents promoted rapid restoration of vascular endothelium compared with DES and persistently impeded inflammation and neointimal hyperplasia in porcine models.</AbstractText>
          <CopyrightInformation>Â© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Rui</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yin</LastName>
            <ForeName>Jiasheng</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Han</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Hongmei</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Fei</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zang</LastName>
            <ForeName>Tongtong</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Rende</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Chenguang</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Yizhe</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Qilin</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fei</LastName>
            <ForeName>Xiang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Meifang</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ge</LastName>
            <ForeName>Junbo</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Bioact Mater</MedlineTA>
        <NlmUniqueID>101685294</NlmUniqueID>
        <ISSNLinking>2452-199X</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Electrospun nanofiber membrane</Keyword>
        <Keyword MajorTopicYN="N">In-stent restenosis</Keyword>
        <Keyword MajorTopicYN="N">Re-endothelialization</Keyword>
        <Keyword MajorTopicYN="N">Reactive oxygen species</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>4</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35600979</ArticleId>
        <ArticleId IdType="pmc">PMC9114161</ArticleId>
        <ArticleId IdType="doi">10.1016/j.bioactmat.2022.04.033</ArticleId>
        <ArticleId IdType="pii">S2452-199X(22)00210-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Townsend N., Wilson L., Bhatnagar P., Wickramasinghe K., Rayner M., Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur. Heart J. 2016;37(42):3232â3245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27523477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu S., Li Y., Zeng X., Wang H., Yin P., Wang L., et al.  Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global burden of disease study. JAMA Cardiol. 2019;4(4):342â352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6484795</ArticleId>
            <ArticleId IdType="pubmed">30865215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng X., Curtis J.P., Hu S., Wang Y., Yang Y., Masoudi F.A., et al.  Coronary catheterization and percutaneous coronary intervention in China: 10-year results from the China PEACE-retrospective CathPCI study. JAMA Intern. Med. 2016;176(4):512â521.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5459379</ArticleId>
            <ArticleId IdType="pubmed">26974883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holmes D.J., Taggart D.P. Revascularization in stable coronary artery disease: a combined perspective from an interventional cardiologist and a cardiac surgeon. Eur. Heart J. 2016;37(24):1873â1882.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26994152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stone G.W., Sabik J.F., Serruys P.W., Simonton C.A., GÃ©nÃ©reux P., Puskas J., et al.  Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N. Engl. J. Med. 2016;375(23):2223â2235.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27797291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Juni R.P., Duckers H.J., Vanhoutte P.M., Virmani R., Moens A.L. Oxidative stress and pathological changes after coronary artery interventions. J. Am. Coll. Cardiol. 2013;61(14):1471â1481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23500310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoue T., Croce K., Morooka T., Sakuma M., Node K., Simon D.I. Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc. Interv. 2011;4(10):1057â1066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3341937</ArticleId>
            <ArticleId IdType="pubmed">22017929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban H.E., Perin M., et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med. 2002;346(23):1773â1780.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12050336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solinas E., Dangas G., Kirtane A.J., Lansky A.J., Franklin-Bond T., Boland P., et al.  Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. Am. J. Cardiol. 2008;102(3):311â315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18638592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finn A.V., Nakazawa G., Joner M., Kolodgie F.D., Mont E.K., Gold H.K., et al.  Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler. Thromb. Vasc. Biol. 2007;27(7):1500â1510.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17510464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu J., Wang R., Shen L., Yin J., Liu G., Chen H., et al.  Enabling topical and long-term anti-radical properties for percutaneous coronary intervention-related complications by incorporating TEMPOL into electrospun nanofibers. Sci. China Mater. 2021;64(3):769â782.</Citation>
        </Reference>
        <Reference>
          <Citation>Jagadeesha D.K., Miller F.J., Bhalla R.C. Inhibition of apoptotic signaling and neointimal hyperplasia by tempol and nitric oxide synthase following vascular injury. J. Vasc. Res. 2009;46(2):109â118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4260720</ArticleId>
            <ArticleId IdType="pubmed">18714161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W., Huo M., Cheng N., Wang R. New forms of electrospun nanofibers applied in cardiovascular field. Front. Cardiovasc. Med. 2021;8:801077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8814313</ArticleId>
            <ArticleId IdType="pubmed">35127862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rafique M., Wei T., Sun Q., Midgley A.C., Huang Z., Wang T., et al.  The effect of hypoxia-mimicking responses on improving the regeneration of artificial vascular grafts. Biomaterials. 2021;271:120746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33725586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi Z., Zhou Y., Fan T., et al.  Inorganic nano-carriers based smart drug delivery systems for tumor therapy. Smart Mater. Med. 2020;1:32â47.</Citation>
        </Reference>
        <Reference>
          <Citation>Hou Y., Deng X., Xie C. Biomaterial surface modification for underwater adhesion. Smart Mater. Med. 2020;1:77â91.</Citation>
        </Reference>
        <Reference>
          <Citation>Serruys P.W., Onuma Y., Ormiston J.A., de Bruyne B., Regar E., Dudek D., et al.  Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122(22):2301â2312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21098436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Prado A.P., PÃ©rez-MartÃ­nez C., Cuellas-RamÃ³n C., Gonzalo-Orden J.M., Regueiro-PurriÃ±os M., MartÃ­nez B., et al.  Time course of reendothelialization of stents in a normal coronary swine model: characterization and quantification. Vet. Pathol. 2011;48(6):1109â1117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21393629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bi H., Feng T., Li B., Han Y. In vitro and in vivo comparison study of electrospun PLA and PLA/PVA/SA fiber membranes for wound healing. Polymers. 2020;12(4)</Citation>
        </Reference>
        <Reference>
          <Citation>Yin A., Luo R., Li J., Mo X., Wang Y., Zhang X. Coaxial electrospinning multicomponent functional controlled-release vascular graft: optimization of graft properties. Colloids Surf. B Biointerfaces. 2017;152:432â439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28178611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., et al.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet (N. Am. Ed.) 2004;364(9444):1519â1521.</Citation>
        </Reference>
        <Reference>
          <Citation>Palmerini T., Biondi-Zoccai G., Della R.D., Mariani A., Genereux P., Branzi A., et al.  Stent thrombosis with drug-eluting stents: is the paradigm shifting? J. Am. Coll. Cardiol. 2013;62(21):1915â1921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24036025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garg P., Mauri L. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Curr. Opin. Cardiol. 2007;22(6):565â571.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17921745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y., Gao P., Huang L., Tan X., Zhou N., Yang T., et al.  A tough nitric oxide-eluting hydrogel coating suppresses neointimal hyperplasia on vascular stent. Nat. Commun. 2021;12(1):7079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8648853</ArticleId>
            <ArticleId IdType="pubmed">34873173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Z., Zhao X., Hao R., Tu Q., Tian X., Xiao Y., et al.  Bioclickable and mussel adhesive peptide mimics for engineering vascular stent surfaces. Proc. Natl. Acad. Sci. U. S. A. 2020;117(28):16127â16137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7368199</ArticleId>
            <ArticleId IdType="pubmed">32601214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y., Gao P., Wang J., Tu Q., Bai L., Xiong K., et al.  Endothelium-mimicking multifunctional coating modified cardiovascular stents via a stepwise metal-catechol-(amine) surface engineering strategy. Research (Wash D C) 2020;2020:9203906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7196174</ArticleId>
            <ArticleId IdType="pubmed">32405627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakamoto A., Torii S., Jinnouchi H., Guo L., Cornelissen A., Kuntz S., et al.  Comparison of endothelial barrier functional recovery after implantation of a novel biodegradable-polymer sirolimus-eluting stent in comparison to durable- and biodegradable-polymer everolimus-eluting stents. Cardiovasc. Revascularization Med. 2021;24:1â10.</Citation>
        </Reference>
        <Reference>
          <Citation>Habib A., Karmali V., Polavarapu R., Akahori H., Cheng Q., Pachura K., et al.  Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-Î± activation and disruption of the p120-vascular endothelial cadherin interaction. Arterioscler. Thromb. Vasc. Biol. 2013;33(10):2425â2431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3827918</ArticleId>
            <ArticleId IdType="pubmed">23887639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nebeker J.R., Virmani R., Bennett C.L., Hoffman J.M., Samore M.H., Alvarez J., et al.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J. Am. Coll. Cardiol. 2006;47(1):175â181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16386683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Virmani R., Guagliumi G., Farb A., Musumeci G., Grieco N., Motta T., et al.  Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109(6):701â705.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14744976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pallero M.A., Talbert R.M., Chen Y.F., Anderson P.G., Lemons J., Brott B.C., et al.  Stainless steel ions stimulate increased thrombospondin-1-dependent TGF-beta activation by vascular smooth muscle cells: implications for in-stent restenosis. J. Vasc. Res. 2010;47(4):309â322.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2895758</ArticleId>
            <ArticleId IdType="pubmed">20016205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Byrne R.A., Joner M., Kastrati A. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol. 2009;57(5):567â584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19838148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kochiadakis G.E., Arfanakis D.A., Marketou M.E., Skalidis E.I., Igoumenidis N.E., Nikitovic D., et al.  Oxidative stress changes after stent implantation: a randomized comparative study of sirolimus-eluting and bare metal stents. Int. J. Cardiol. 2010;142(1):33â37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19168247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jabs A., GÃ¶bel S., Wenzel P., Kleschyov A.L., Hortmann M., Oelze M., et al.  Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation. J. Am. Coll. Cardiol. 2008;51(22):2130â2138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18510959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pendyala L.K., Li J., Shinke T., Geva S., Yin X., Chen J.P., et al.  Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress. JACC Cardiovasc. Interv. 2009;2(3):253â262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19463433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah P.K. Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken. Circulation. 2003;107(17):2175â2177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12732592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma J., Liu X., Qiao L., Meng L., Xu X., Xue F., et al.  Association between stent implantation and progression of nontarget lesions in a rabbit model of atherosclerosis. Circ. Cardiovasc. Interv. 2021;14(11)</Citation>
        </Reference>
        <Reference>
          <Citation>Diaz-Rodriguez S., Rasser C., Mesnier J., Chevallier P., Gallet R., Choqueux C., et al.  Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo. Eur. Heart J. 2021;42(18):1760â1769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8106951</ArticleId>
            <ArticleId IdType="pubmed">33580685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez D., Owens G.K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc. Res. 2012;95(2):156â164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3388816</ArticleId>
            <ArticleId IdType="pubmed">22406749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu Q.B., Wan M.Y., Wang P.Y., Zhang C.X., Xu D.Y., Liao X., et al.  Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFÎºB/mTOR/P70S6K signaling cascade. Redox Biol. 2018;14:656â668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5716955</ArticleId>
            <ArticleId IdType="pubmed">29175753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohtani K., Egashira K., Ihara Y., Nakano K., Funakoshi K., Zhao G., et al.  Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells. Hypertension. 2006;48(4):664â670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16940231</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35600979</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-199X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>19</Volume>
            <PubDate>
              <Year>2023</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Bioactive materials</Title>
          <ISOAbbreviation>Bioact Mater</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation.</ArticleTitle>
        <Pagination>
          <StartPage>666</StartPage>
          <EndPage>677</EndPage>
          <MedlinePgn>666-677</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bioactmat.2022.04.033</ELocationID>
        <Abstract>
          <AbstractText>An increased level of reactive oxygen species (ROS) plays a major role in endothelial dysfunction and vascular smooth muscle cell (VSMC) proliferation during in-stent thrombosis and restenosis after coronary artery stenting. Herein, we report an electrospun core-shell nanofiber coloaded with 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPOL) and rapamycin (RAPA) that correspondingly serves as an ROS scavenger and VSMC inhibitor. This system has the potential to improve the biocompatibility of current drug-eluting stent (DES) coatings with the long-term and continuous release of TEMPOL and rapamycin. Moreover, the RAPA/TEMPOL-loaded membrane selectively inhibited the proliferation of VSMCs while sparing endothelial cells (ECs). This membrane demonstrated superior ROS-scavenging, anti-inflammatory and antithrombogenic effects in ECs. In addition, the membrane could maintain the contractile phenotype and mitigate platelet-derived growth factor BB (PDGF-BB)-induced proliferation of VSMCs. <i>In vivo</i> results further revealed that the RAPA/TEMPOL-loaded covered stents promoted rapid restoration of vascular endothelium compared with DES and persistently impeded inflammation and neointimal hyperplasia in porcine models.</AbstractText>
          <CopyrightInformation>Â© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Rui</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yin</LastName>
            <ForeName>Jiasheng</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Han</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Hongmei</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Fei</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zang</LastName>
            <ForeName>Tongtong</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Rende</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Chenguang</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Yizhe</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Qilin</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fei</LastName>
            <ForeName>Xiang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Meifang</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ge</LastName>
            <ForeName>Junbo</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Bioact Mater</MedlineTA>
        <NlmUniqueID>101685294</NlmUniqueID>
        <ISSNLinking>2452-199X</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Electrospun nanofiber membrane</Keyword>
        <Keyword MajorTopicYN="N">In-stent restenosis</Keyword>
        <Keyword MajorTopicYN="N">Re-endothelialization</Keyword>
        <Keyword MajorTopicYN="N">Reactive oxygen species</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>4</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35600979</ArticleId>
        <ArticleId IdType="pmc">PMC9114161</ArticleId>
        <ArticleId IdType="doi">10.1016/j.bioactmat.2022.04.033</ArticleId>
        <ArticleId IdType="pii">S2452-199X(22)00210-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Townsend N., Wilson L., Bhatnagar P., Wickramasinghe K., Rayner M., Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur. Heart J. 2016;37(42):3232â3245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27523477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu S., Li Y., Zeng X., Wang H., Yin P., Wang L., et al.  Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global burden of disease study. JAMA Cardiol. 2019;4(4):342â352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6484795</ArticleId>
            <ArticleId IdType="pubmed">30865215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng X., Curtis J.P., Hu S., Wang Y., Yang Y., Masoudi F.A., et al.  Coronary catheterization and percutaneous coronary intervention in China: 10-year results from the China PEACE-retrospective CathPCI study. JAMA Intern. Med. 2016;176(4):512â521.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5459379</ArticleId>
            <ArticleId IdType="pubmed">26974883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holmes D.J., Taggart D.P. Revascularization in stable coronary artery disease: a combined perspective from an interventional cardiologist and a cardiac surgeon. Eur. Heart J. 2016;37(24):1873â1882.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26994152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stone G.W., Sabik J.F., Serruys P.W., Simonton C.A., GÃ©nÃ©reux P., Puskas J., et al.  Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N. Engl. J. Med. 2016;375(23):2223â2235.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27797291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Juni R.P., Duckers H.J., Vanhoutte P.M., Virmani R., Moens A.L. Oxidative stress and pathological changes after coronary artery interventions. J. Am. Coll. Cardiol. 2013;61(14):1471â1481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23500310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoue T., Croce K., Morooka T., Sakuma M., Node K., Simon D.I. Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc. Interv. 2011;4(10):1057â1066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3341937</ArticleId>
            <ArticleId IdType="pubmed">22017929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban H.E., Perin M., et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med. 2002;346(23):1773â1780.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12050336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solinas E., Dangas G., Kirtane A.J., Lansky A.J., Franklin-Bond T., Boland P., et al.  Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. Am. J. Cardiol. 2008;102(3):311â315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18638592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finn A.V., Nakazawa G., Joner M., Kolodgie F.D., Mont E.K., Gold H.K., et al.  Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler. Thromb. Vasc. Biol. 2007;27(7):1500â1510.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17510464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu J., Wang R., Shen L., Yin J., Liu G., Chen H., et al.  Enabling topical and long-term anti-radical properties for percutaneous coronary intervention-related complications by incorporating TEMPOL into electrospun nanofibers. Sci. China Mater. 2021;64(3):769â782.</Citation>
        </Reference>
        <Reference>
          <Citation>Jagadeesha D.K., Miller F.J., Bhalla R.C. Inhibition of apoptotic signaling and neointimal hyperplasia by tempol and nitric oxide synthase following vascular injury. J. Vasc. Res. 2009;46(2):109â118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4260720</ArticleId>
            <ArticleId IdType="pubmed">18714161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W., Huo M., Cheng N., Wang R. New forms of electrospun nanofibers applied in cardiovascular field. Front. Cardiovasc. Med. 2021;8:801077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8814313</ArticleId>
            <ArticleId IdType="pubmed">35127862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rafique M., Wei T., Sun Q., Midgley A.C., Huang Z., Wang T., et al.  The effect of hypoxia-mimicking responses on improving the regeneration of artificial vascular grafts. Biomaterials. 2021;271:120746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33725586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi Z., Zhou Y., Fan T., et al.  Inorganic nano-carriers based smart drug delivery systems for tumor therapy. Smart Mater. Med. 2020;1:32â47.</Citation>
        </Reference>
        <Reference>
          <Citation>Hou Y., Deng X., Xie C. Biomaterial surface modification for underwater adhesion. Smart Mater. Med. 2020;1:77â91.</Citation>
        </Reference>
        <Reference>
          <Citation>Serruys P.W., Onuma Y., Ormiston J.A., de Bruyne B., Regar E., Dudek D., et al.  Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122(22):2301â2312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21098436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Prado A.P., PÃ©rez-MartÃ­nez C., Cuellas-RamÃ³n C., Gonzalo-Orden J.M., Regueiro-PurriÃ±os M., MartÃ­nez B., et al.  Time course of reendothelialization of stents in a normal coronary swine model: characterization and quantification. Vet. Pathol. 2011;48(6):1109â1117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21393629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bi H., Feng T., Li B., Han Y. In vitro and in vivo comparison study of electrospun PLA and PLA/PVA/SA fiber membranes for wound healing. Polymers. 2020;12(4)</Citation>
        </Reference>
        <Reference>
          <Citation>Yin A., Luo R., Li J., Mo X., Wang Y., Zhang X. Coaxial electrospinning multicomponent functional controlled-release vascular graft: optimization of graft properties. Colloids Surf. B Biointerfaces. 2017;152:432â439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28178611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., et al.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet (N. Am. Ed.) 2004;364(9444):1519â1521.</Citation>
        </Reference>
        <Reference>
          <Citation>Palmerini T., Biondi-Zoccai G., Della R.D., Mariani A., Genereux P., Branzi A., et al.  Stent thrombosis with drug-eluting stents: is the paradigm shifting? J. Am. Coll. Cardiol. 2013;62(21):1915â1921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24036025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garg P., Mauri L. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Curr. Opin. Cardiol. 2007;22(6):565â571.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17921745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y., Gao P., Huang L., Tan X., Zhou N., Yang T., et al.  A tough nitric oxide-eluting hydrogel coating suppresses neointimal hyperplasia on vascular stent. Nat. Commun. 2021;12(1):7079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8648853</ArticleId>
            <ArticleId IdType="pubmed">34873173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Z., Zhao X., Hao R., Tu Q., Tian X., Xiao Y., et al.  Bioclickable and mussel adhesive peptide mimics for engineering vascular stent surfaces. Proc. Natl. Acad. Sci. U. S. A. 2020;117(28):16127â16137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7368199</ArticleId>
            <ArticleId IdType="pubmed">32601214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y., Gao P., Wang J., Tu Q., Bai L., Xiong K., et al.  Endothelium-mimicking multifunctional coating modified cardiovascular stents via a stepwise metal-catechol-(amine) surface engineering strategy. Research (Wash D C) 2020;2020:9203906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7196174</ArticleId>
            <ArticleId IdType="pubmed">32405627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakamoto A., Torii S., Jinnouchi H., Guo L., Cornelissen A., Kuntz S., et al.  Comparison of endothelial barrier functional recovery after implantation of a novel biodegradable-polymer sirolimus-eluting stent in comparison to durable- and biodegradable-polymer everolimus-eluting stents. Cardiovasc. Revascularization Med. 2021;24:1â10.</Citation>
        </Reference>
        <Reference>
          <Citation>Habib A., Karmali V., Polavarapu R., Akahori H., Cheng Q., Pachura K., et al.  Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-Î± activation and disruption of the p120-vascular endothelial cadherin interaction. Arterioscler. Thromb. Vasc. Biol. 2013;33(10):2425â2431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3827918</ArticleId>
            <ArticleId IdType="pubmed">23887639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nebeker J.R., Virmani R., Bennett C.L., Hoffman J.M., Samore M.H., Alvarez J., et al.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J. Am. Coll. Cardiol. 2006;47(1):175â181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16386683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Virmani R., Guagliumi G., Farb A., Musumeci G., Grieco N., Motta T., et al.  Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109(6):701â705.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14744976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pallero M.A., Talbert R.M., Chen Y.F., Anderson P.G., Lemons J., Brott B.C., et al.  Stainless steel ions stimulate increased thrombospondin-1-dependent TGF-beta activation by vascular smooth muscle cells: implications for in-stent restenosis. J. Vasc. Res. 2010;47(4):309â322.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2895758</ArticleId>
            <ArticleId IdType="pubmed">20016205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Byrne R.A., Joner M., Kastrati A. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol. 2009;57(5):567â584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19838148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kochiadakis G.E., Arfanakis D.A., Marketou M.E., Skalidis E.I., Igoumenidis N.E., Nikitovic D., et al.  Oxidative stress changes after stent implantation: a randomized comparative study of sirolimus-eluting and bare metal stents. Int. J. Cardiol. 2010;142(1):33â37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19168247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jabs A., GÃ¶bel S., Wenzel P., Kleschyov A.L., Hortmann M., Oelze M., et al.  Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation. J. Am. Coll. Cardiol. 2008;51(22):2130â2138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18510959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pendyala L.K., Li J., Shinke T., Geva S., Yin X., Chen J.P., et al.  Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress. JACC Cardiovasc. Interv. 2009;2(3):253â262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19463433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah P.K. Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken. Circulation. 2003;107(17):2175â2177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12732592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma J., Liu X., Qiao L., Meng L., Xu X., Xue F., et al.  Association between stent implantation and progression of nontarget lesions in a rabbit model of atherosclerosis. Circ. Cardiovasc. Interv. 2021;14(11)</Citation>
        </Reference>
        <Reference>
          <Citation>Diaz-Rodriguez S., Rasser C., Mesnier J., Chevallier P., Gallet R., Choqueux C., et al.  Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo. Eur. Heart J. 2021;42(18):1760â1769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8106951</ArticleId>
            <ArticleId IdType="pubmed">33580685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez D., Owens G.K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc. Res. 2012;95(2):156â164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3388816</ArticleId>
            <ArticleId IdType="pubmed">22406749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu Q.B., Wan M.Y., Wang P.Y., Zhang C.X., Xu D.Y., Liao X., et al.  Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFÎºB/mTOR/P70S6K signaling cascade. Redox Biol. 2018;14:656â668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5716955</ArticleId>
            <ArticleId IdType="pubmed">29175753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohtani K., Egashira K., Ihara Y., Nakano K., Funakoshi K., Zhao G., et al.  Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells. Hypertension. 2006;48(4):664â670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16940231</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35600979</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-199X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>19</Volume>
            <PubDate>
              <Year>2023</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Bioactive materials</Title>
          <ISOAbbreviation>Bioact Mater</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation.</ArticleTitle>
        <Pagination>
          <StartPage>666</StartPage>
          <EndPage>677</EndPage>
          <MedlinePgn>666-677</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bioactmat.2022.04.033</ELocationID>
        <Abstract>
          <AbstractText>An increased level of reactive oxygen species (ROS) plays a major role in endothelial dysfunction and vascular smooth muscle cell (VSMC) proliferation during in-stent thrombosis and restenosis after coronary artery stenting. Herein, we report an electrospun core-shell nanofiber coloaded with 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPOL) and rapamycin (RAPA) that correspondingly serves as an ROS scavenger and VSMC inhibitor. This system has the potential to improve the biocompatibility of current drug-eluting stent (DES) coatings with the long-term and continuous release of TEMPOL and rapamycin. Moreover, the RAPA/TEMPOL-loaded membrane selectively inhibited the proliferation of VSMCs while sparing endothelial cells (ECs). This membrane demonstrated superior ROS-scavenging, anti-inflammatory and antithrombogenic effects in ECs. In addition, the membrane could maintain the contractile phenotype and mitigate platelet-derived growth factor BB (PDGF-BB)-induced proliferation of VSMCs. <i>In vivo</i> results further revealed that the RAPA/TEMPOL-loaded covered stents promoted rapid restoration of vascular endothelium compared with DES and persistently impeded inflammation and neointimal hyperplasia in porcine models.</AbstractText>
          <CopyrightInformation>Â© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Rui</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yin</LastName>
            <ForeName>Jiasheng</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Han</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Hongmei</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Fei</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zang</LastName>
            <ForeName>Tongtong</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Rende</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Chenguang</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Yizhe</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Qilin</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fei</LastName>
            <ForeName>Xiang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Meifang</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, International Joint Laboratory for Advanced Fiber and Low-dimension Materials, Donghua University, Shanghai, 201620, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ge</LastName>
            <ForeName>Junbo</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Research Unit of Cardiovascular Techniques and Devices, Chinese Academy of Medical Sciences, Shanghai, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shanghai Engineering Research Center of Interventional Medicine, Shanghai, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Bioact Mater</MedlineTA>
        <NlmUniqueID>101685294</NlmUniqueID>
        <ISSNLinking>2452-199X</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Electrospun nanofiber membrane</Keyword>
        <Keyword MajorTopicYN="N">In-stent restenosis</Keyword>
        <Keyword MajorTopicYN="N">Re-endothelialization</Keyword>
        <Keyword MajorTopicYN="N">Reactive oxygen species</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>4</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35600979</ArticleId>
        <ArticleId IdType="pmc">PMC9114161</ArticleId>
        <ArticleId IdType="doi">10.1016/j.bioactmat.2022.04.033</ArticleId>
        <ArticleId IdType="pii">S2452-199X(22)00210-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Townsend N., Wilson L., Bhatnagar P., Wickramasinghe K., Rayner M., Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur. Heart J. 2016;37(42):3232â3245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27523477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu S., Li Y., Zeng X., Wang H., Yin P., Wang L., et al.  Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global burden of disease study. JAMA Cardiol. 2019;4(4):342â352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6484795</ArticleId>
            <ArticleId IdType="pubmed">30865215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng X., Curtis J.P., Hu S., Wang Y., Yang Y., Masoudi F.A., et al.  Coronary catheterization and percutaneous coronary intervention in China: 10-year results from the China PEACE-retrospective CathPCI study. JAMA Intern. Med. 2016;176(4):512â521.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5459379</ArticleId>
            <ArticleId IdType="pubmed">26974883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holmes D.J., Taggart D.P. Revascularization in stable coronary artery disease: a combined perspective from an interventional cardiologist and a cardiac surgeon. Eur. Heart J. 2016;37(24):1873â1882.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26994152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stone G.W., Sabik J.F., Serruys P.W., Simonton C.A., GÃ©nÃ©reux P., Puskas J., et al.  Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N. Engl. J. Med. 2016;375(23):2223â2235.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27797291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Juni R.P., Duckers H.J., Vanhoutte P.M., Virmani R., Moens A.L. Oxidative stress and pathological changes after coronary artery interventions. J. Am. Coll. Cardiol. 2013;61(14):1471â1481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23500310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoue T., Croce K., Morooka T., Sakuma M., Node K., Simon D.I. Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc. Interv. 2011;4(10):1057â1066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3341937</ArticleId>
            <ArticleId IdType="pubmed">22017929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban H.E., Perin M., et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med. 2002;346(23):1773â1780.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12050336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solinas E., Dangas G., Kirtane A.J., Lansky A.J., Franklin-Bond T., Boland P., et al.  Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. Am. J. Cardiol. 2008;102(3):311â315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18638592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finn A.V., Nakazawa G., Joner M., Kolodgie F.D., Mont E.K., Gold H.K., et al.  Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler. Thromb. Vasc. Biol. 2007;27(7):1500â1510.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17510464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu J., Wang R., Shen L., Yin J., Liu G., Chen H., et al.  Enabling topical and long-term anti-radical properties for percutaneous coronary intervention-related complications by incorporating TEMPOL into electrospun nanofibers. Sci. China Mater. 2021;64(3):769â782.</Citation>
        </Reference>
        <Reference>
          <Citation>Jagadeesha D.K., Miller F.J., Bhalla R.C. Inhibition of apoptotic signaling and neointimal hyperplasia by tempol and nitric oxide synthase following vascular injury. J. Vasc. Res. 2009;46(2):109â118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4260720</ArticleId>
            <ArticleId IdType="pubmed">18714161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W., Huo M., Cheng N., Wang R. New forms of electrospun nanofibers applied in cardiovascular field. Front. Cardiovasc. Med. 2021;8:801077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8814313</ArticleId>
            <ArticleId IdType="pubmed">35127862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rafique M., Wei T., Sun Q., Midgley A.C., Huang Z., Wang T., et al.  The effect of hypoxia-mimicking responses on improving the regeneration of artificial vascular grafts. Biomaterials. 2021;271:120746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33725586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi Z., Zhou Y., Fan T., et al.  Inorganic nano-carriers based smart drug delivery systems for tumor therapy. Smart Mater. Med. 2020;1:32â47.</Citation>
        </Reference>
        <Reference>
          <Citation>Hou Y., Deng X., Xie C. Biomaterial surface modification for underwater adhesion. Smart Mater. Med. 2020;1:77â91.</Citation>
        </Reference>
        <Reference>
          <Citation>Serruys P.W., Onuma Y., Ormiston J.A., de Bruyne B., Regar E., Dudek D., et al.  Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122(22):2301â2312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21098436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Prado A.P., PÃ©rez-MartÃ­nez C., Cuellas-RamÃ³n C., Gonzalo-Orden J.M., Regueiro-PurriÃ±os M., MartÃ­nez B., et al.  Time course of reendothelialization of stents in a normal coronary swine model: characterization and quantification. Vet. Pathol. 2011;48(6):1109â1117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21393629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bi H., Feng T., Li B., Han Y. In vitro and in vivo comparison study of electrospun PLA and PLA/PVA/SA fiber membranes for wound healing. Polymers. 2020;12(4)</Citation>
        </Reference>
        <Reference>
          <Citation>Yin A., Luo R., Li J., Mo X., Wang Y., Zhang X. Coaxial electrospinning multicomponent functional controlled-release vascular graft: optimization of graft properties. Colloids Surf. B Biointerfaces. 2017;152:432â439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28178611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., et al.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet (N. Am. Ed.) 2004;364(9444):1519â1521.</Citation>
        </Reference>
        <Reference>
          <Citation>Palmerini T., Biondi-Zoccai G., Della R.D., Mariani A., Genereux P., Branzi A., et al.  Stent thrombosis with drug-eluting stents: is the paradigm shifting? J. Am. Coll. Cardiol. 2013;62(21):1915â1921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24036025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garg P., Mauri L. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Curr. Opin. Cardiol. 2007;22(6):565â571.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17921745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y., Gao P., Huang L., Tan X., Zhou N., Yang T., et al.  A tough nitric oxide-eluting hydrogel coating suppresses neointimal hyperplasia on vascular stent. Nat. Commun. 2021;12(1):7079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8648853</ArticleId>
            <ArticleId IdType="pubmed">34873173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Z., Zhao X., Hao R., Tu Q., Tian X., Xiao Y., et al.  Bioclickable and mussel adhesive peptide mimics for engineering vascular stent surfaces. Proc. Natl. Acad. Sci. U. S. A. 2020;117(28):16127â16137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7368199</ArticleId>
            <ArticleId IdType="pubmed">32601214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y., Gao P., Wang J., Tu Q., Bai L., Xiong K., et al.  Endothelium-mimicking multifunctional coating modified cardiovascular stents via a stepwise metal-catechol-(amine) surface engineering strategy. Research (Wash D C) 2020;2020:9203906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7196174</ArticleId>
            <ArticleId IdType="pubmed">32405627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakamoto A., Torii S., Jinnouchi H., Guo L., Cornelissen A., Kuntz S., et al.  Comparison of endothelial barrier functional recovery after implantation of a novel biodegradable-polymer sirolimus-eluting stent in comparison to durable- and biodegradable-polymer everolimus-eluting stents. Cardiovasc. Revascularization Med. 2021;24:1â10.</Citation>
        </Reference>
        <Reference>
          <Citation>Habib A., Karmali V., Polavarapu R., Akahori H., Cheng Q., Pachura K., et al.  Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-Î± activation and disruption of the p120-vascular endothelial cadherin interaction. Arterioscler. Thromb. Vasc. Biol. 2013;33(10):2425â2431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3827918</ArticleId>
            <ArticleId IdType="pubmed">23887639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nebeker J.R., Virmani R., Bennett C.L., Hoffman J.M., Samore M.H., Alvarez J., et al.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J. Am. Coll. Cardiol. 2006;47(1):175â181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16386683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Virmani R., Guagliumi G., Farb A., Musumeci G., Grieco N., Motta T., et al.  Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109(6):701â705.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14744976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pallero M.A., Talbert R.M., Chen Y.F., Anderson P.G., Lemons J., Brott B.C., et al.  Stainless steel ions stimulate increased thrombospondin-1-dependent TGF-beta activation by vascular smooth muscle cells: implications for in-stent restenosis. J. Vasc. Res. 2010;47(4):309â322.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2895758</ArticleId>
            <ArticleId IdType="pubmed">20016205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Byrne R.A., Joner M., Kastrati A. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol. 2009;57(5):567â584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19838148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kochiadakis G.E., Arfanakis D.A., Marketou M.E., Skalidis E.I., Igoumenidis N.E., Nikitovic D., et al.  Oxidative stress changes after stent implantation: a randomized comparative study of sirolimus-eluting and bare metal stents. Int. J. Cardiol. 2010;142(1):33â37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19168247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jabs A., GÃ¶bel S., Wenzel P., Kleschyov A.L., Hortmann M., Oelze M., et al.  Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation. J. Am. Coll. Cardiol. 2008;51(22):2130â2138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18510959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pendyala L.K., Li J., Shinke T., Geva S., Yin X., Chen J.P., et al.  Endothelium-dependent vasomotor dysfunction in pig coronary arteries with Paclitaxel-eluting stents is associated with inflammation and oxidative stress. JACC Cardiovasc. Interv. 2009;2(3):253â262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19463433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah P.K. Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken. Circulation. 2003;107(17):2175â2177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12732592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma J., Liu X., Qiao L., Meng L., Xu X., Xue F., et al.  Association between stent implantation and progression of nontarget lesions in a rabbit model of atherosclerosis. Circ. Cardiovasc. Interv. 2021;14(11)</Citation>
        </Reference>
        <Reference>
          <Citation>Diaz-Rodriguez S., Rasser C., Mesnier J., Chevallier P., Gallet R., Choqueux C., et al.  Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo. Eur. Heart J. 2021;42(18):1760â1769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8106951</ArticleId>
            <ArticleId IdType="pubmed">33580685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez D., Owens G.K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc. Res. 2012;95(2):156â164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3388816</ArticleId>
            <ArticleId IdType="pubmed">22406749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu Q.B., Wan M.Y., Wang P.Y., Zhang C.X., Xu D.Y., Liao X., et al.  Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFÎºB/mTOR/P70S6K signaling cascade. Redox Biol. 2018;14:656â668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5716955</ArticleId>
            <ArticleId IdType="pubmed">29175753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohtani K., Egashira K., Ihara Y., Nakano K., Funakoshi K., Zhao G., et al.  Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells. Hypertension. 2006;48(4):664â670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16940231</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
